Roche Holding AG (RHHBF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Basel, Switzerland. The current CEO is Thomas Schinecker.
RHHBF has IPO date of 2012-08-03, 103,249 full-time employees, listed on the Other OTC, a market capitalization of $333.13B.
Roche Holding AG is a Swiss-based pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. Roche also operates a substantial diagnostics business providing in vitro testing for disease diagnosis, including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. With operations spanning Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and other international markets, Roche maintains research collaborations to develop innovative therapies, including synthetic biologics for inflammatory bowel disease treatment.
